Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

Yiping Yang, Chang Tai Huang, Xiaopei Huang, Andrew Mark Pardoll

Research output: Contribution to journalArticle

Abstract

One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8+ T cells. However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4+CD25+ regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the coadministration of a Toll-like receptor (TLR) ligand or irrelevant virus. These results demonstrate that virus provides TLR signals required for bypassing regulatory T cell-mediated tolerance and emphasize the importance of persistent TLR signals for immunotherapy in the setting of established tolerance.

Original languageEnglish (US)
Pages (from-to)508-515
Number of pages8
JournalNature Immunology
Volume5
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Toll-Like Receptors
Hemagglutinins
Regulatory T-Lymphocytes
Viruses
Immunotherapy
Dendritic Cells
Vaccines
Viral Vaccines
T-Lymphocytes
Neoplasms
Ligands

ASJC Scopus subject areas

  • Immunology

Cite this

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. / Yang, Yiping; Huang, Chang Tai; Huang, Xiaopei; Pardoll, Andrew Mark.

In: Nature Immunology, Vol. 5, No. 5, 05.2004, p. 508-515.

Research output: Contribution to journalArticle

@article{0d362c1e91ac4d0ab93ef54407c247b0,
title = "Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance",
abstract = "One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8+ T cells. However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4+CD25+ regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the coadministration of a Toll-like receptor (TLR) ligand or irrelevant virus. These results demonstrate that virus provides TLR signals required for bypassing regulatory T cell-mediated tolerance and emphasize the importance of persistent TLR signals for immunotherapy in the setting of established tolerance.",
author = "Yiping Yang and Huang, {Chang Tai} and Xiaopei Huang and Pardoll, {Andrew Mark}",
year = "2004",
month = "5",
doi = "10.1038/ni1059",
language = "English (US)",
volume = "5",
pages = "508--515",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

AU - Yang, Yiping

AU - Huang, Chang Tai

AU - Huang, Xiaopei

AU - Pardoll, Andrew Mark

PY - 2004/5

Y1 - 2004/5

N2 - One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8+ T cells. However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4+CD25+ regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the coadministration of a Toll-like receptor (TLR) ligand or irrelevant virus. These results demonstrate that virus provides TLR signals required for bypassing regulatory T cell-mediated tolerance and emphasize the importance of persistent TLR signals for immunotherapy in the setting of established tolerance.

AB - One chief barrier to cancer immunotherapy is tumor-specific T cell tolerance. Here we compared the ability of hemagglutinin (HA)-encoding recombinant viruses versus 'HA-loaded' dendritic cells to reverse HA-specific CD8 tolerance and to protect mice from tumor challenge. Both vaccines were comparable in activating naive HA-specific CD8+ T cells. However, in circumstances of established tolerance, viral vaccines could break CD8 tolerance in the presence of CD4+CD25+ regulatory T cells, whereas dendritic cell-based vaccines achieved this only after removal of regulatory T cells or the coadministration of a Toll-like receptor (TLR) ligand or irrelevant virus. These results demonstrate that virus provides TLR signals required for bypassing regulatory T cell-mediated tolerance and emphasize the importance of persistent TLR signals for immunotherapy in the setting of established tolerance.

UR - http://www.scopus.com/inward/record.url?scp=2442655250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442655250&partnerID=8YFLogxK

U2 - 10.1038/ni1059

DO - 10.1038/ni1059

M3 - Article

VL - 5

SP - 508

EP - 515

JO - Nature Immunology

JF - Nature Immunology

SN - 1529-2908

IS - 5

ER -